Xlife Sciences AG (SWX:XLS)

Market Cap	120.58M
Revenue (ttm)	834.88K
Net Income (ttm)	34.28M
Shares Out	5.74M
EPS (ttm)	4.54
PE Ratio	4.63
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,399
Average Volume	6,137
Open	21.30
Previous Close	21.10
Day's Range	20.00 - 21.30
52-Week Range	16.55 - 39.00
Beta	0.39
RSI	46.36
Earnings Date	Apr 25, 2025

About Xlife Sciences AG

Xlife Sciences AG focuses on the development and commercialization of technologies in the life sciences sector. The company’s project consists of technology platforms that focuses on identifying new therapeutic approaches and biomarkers for common diseases based on human genetic data. It also engages biotech and therapies medical technology and artificial intelligence adequate risk diversification; medical offers technology project engages in biotech and therapies, medical technology and artificial intelligence. In addition, the company support...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2019
• Employees: 17
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: XLS

Financial Performance

In 2024, Xlife Sciences AG's revenue was 834,877, a decrease of -15.54% compared to the previous year's 988,435. Earnings were 34.28 million, an increase of 130.37%.